Similar Articles

Home | Newsletter | My Articles | My Account | Help

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 13, 2004 Rich Duprey	Cima's Breakup Mess The pharmaceutical company seeks to recoup its fees plus damages from a former suitor.
The Motley Fool June 21, 2004 Rich Duprey	aaiPharma Feels the Pain The maker of painkiller Darvocet restates its earnings for the prior two years.
The Motley Fool April 7, 2005 Rich Duprey	Gambling on aaiPharma's Bankruptcy Some investors take a flier as this specialty pharmaceutical careens toward bankruptcy.
The Motley Fool July 16, 2004 Rich Duprey	aaiPharma's Headache Lingers The tiny pharmaceutical company regains its ticker symbol, but controversy still reigns. Facing a raft of class action lawsuits, shareholders may wonder whether samples of painkiller Darvon will be included with their annual reports
The Motley Fool July 15, 2004 Brian Gorman	Research Company's Stock Surges PPD's (formerly Pharmaceutical Product Development) second-quarter report isn't perfect, but long-term indicators look solid. The stock has risen as much as 14%.